Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Anicura Københavns Dyrehospital ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.1% 6.7% 3.0% 1.1% 0.7% 0.7% 9.3% 9.2%   Credit score (0-100)   86 37 58 83 93 93 26 7   Credit rating   BBB BB BB BBB A A B B   Credit limit (kDKK)   477.2 0.0 0.0 761.9 2,718.9 2,983.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   23,481 24,158 26,873 38,779 43,765 42,678 0.0 0.0   EBITDA   1,985 -183 2,613 8,595 8,712 5,038 0.0 0.0   EBIT   251 -2,154 626 7,721 7,867 4,287 0.0 0.0   Pre-tax profit (PTP)   426.6 -2,089.6 677.7 7,815.0 8,021.9 5,135.0 0.0 0.0   Net earnings   426.6 -2,089.6 677.7 7,815.0 8,021.9 5,135.0 0.0 0.0   Pre-tax profit without non-rec. items   427 -2,090 678 7,815 8,022 5,135 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   2,990 3,182 2,496 2,592 2,523 3,349 0.0 0.0   Shareholders equity total   5,900 911 1,588 9,403 17,425 22,560 21,800 21,800   Interest-bearing liabilities   2,009 734 39.3 1,155 3,309 847 0.0 0.0   Balance sheet total (assets)   14,210 7,974 9,241 22,326 26,369 28,264 21,800 21,800   Net Debt   1,440 593 -167 1,148 3,188 740 -21,800 -21,800     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   23,481 24,158 26,873 38,779 43,765 42,678 0.0 0.0   Gross profit growth   8.7% 2.9% 11.2% 44.3% 12.9% -2.5% -100.0% 0.0%   Employees   46 54 51 59 59 72 0 0   Employee growth %   9.5% 17.4% -5.6% 15.7% 0.0% 22.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   14,210 7,974 9,241 22,326 26,369 28,264 21,800 21,800   Balance sheet change%   8.0% -43.9% 15.9% 141.6% 18.1% 7.2% -22.9% 0.0%   Added value   1,984.9 -182.6 2,612.8 8,595.4 8,741.9 5,038.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -2,315 -2,623 -3,516 -778 -913 74 -3,349 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1.1% -8.9% 2.3% 19.9% 18.0% 10.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.2% -18.7% 8.0% 49.5% 33.0% 18.8% 0.0% 0.0%   ROI %   5.4% -43.5% 33.2% 101.9% 47.8% 23.3% 0.0% 0.0%   ROE %   7.5% -61.4% 54.2% 142.2% 59.8% 25.7% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   41.5% 11.4% 17.2% 42.1% 66.1% 79.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   72.6% -324.9% -6.4% 13.4% 36.6% 14.7% 0.0% 0.0%   Gearing %   34.1% 80.6% 2.5% 12.3% 19.0% 3.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 0.9% 2.3% 0.3% 0.4% 0.4% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.1 0.5 0.8 1.8 2.5 4.2 0.0 0.0   Current Ratio   1.1 0.6 1.0 1.9 2.7 4.4 0.0 0.0   Cash and cash equivalent   568.7 140.9 206.1 7.0 120.7 107.5 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,224.5 -3,113.9 -40.0 9,104.6 14,902.0 19,211.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   43 -3 51 146 148 70 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   43 -3 51 146 148 70 0 0   EBIT / employee   5 -40 12 131 133 60 0 0   Net earnings / employee   9 -39 13 132 136 71 0 0